Search results
Results from the WOW.Com Content Network
The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency ( EMEA ).
Regulation (EC) No 536/2014; European Union regulation: Title: Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance
EMA was set up on 1 April 2001 to take over the regulatory functions of the Public Utilities Board, and the operations of the power grid by SP PowerGrid.. It aims to ensure a reliable and secure energy supply, promote effective competition in the energy market and develop a dynamic energy sector in Singapore.
The annual report on the state of the drugs problem in the European Union and Norway and an online statistical bulletin offer a yearly overview of the latest European drug situation and trends. Meanwhile, online country situation summaries provide a pool of national drug-related data.
The regulator's public assessment report for the vaccine was published in 15 December. [27] The MHRA went on to give conditional and temporary authorization to supply of further vaccines: AZD1222 from Oxford University and AstraZeneca on 30 December, [28] mRNA-1273 from Moderna on 8 January 2021, [29] and a single-dose vaccine from Janssen on ...
She is a Scientific Committee Member and expert with the European Medicines Agency. [12] She was awarded an OBE for services to the regulation of public health in the 2018 New Years Honours. [13] She was acting President of the Royal College of Physicians of Edinburgh (RCPE) from June 2020 through June 2021 [14]
The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a Directorate and partial agreement of the Council of Europe that traces its origins and statutes to the Convention on the Elaboration of a European Pharmacopoeia (an international treaty adopted by the Council of Europe in 1964: ETS 50, [2] Protocol [3]).
In 2016, the Swedish National Audit Office published an audit report examining how the state (the government, the Medical Products Agency, the National Board of Health and Welfare and the Swedish Agency for Medical and Social Evaluation) handles the pharmaceutical industry's influence over state drug control and knowledge management. [1]